financetom
Business
financetom
/
Business
/
Integral Metals Up After Upsizing Private Placement to up to C$3 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Integral Metals Up After Upsizing Private Placement to up to C$3 Million
Oct 14, 2025 7:44 AM

10:21 AM EDT, 10/14/2025 (MT Newswires) -- Integral Metals ( ITGLF ) shares rose 4.3% Tuesday after it upsized its previously announced private placement offering to $3 million from $2 million, at $0.80 apiece.

Each unit will be comprised of one common share and one two-year warrant, with each warrant entitling the holder to buy a share for $0.95. Proceeds will be used to fund exploration activities, and for working capital and general corporate needs.

The company said the offering is expected to close on or about October 23.

Shares of the company were last seen up $0.04 at $0.98 on the Canadian Securities Exchange.

Price: 0.99, Change: +0.05, Percent Change: +5.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Nov 4, 2024
Nov 4 (Reuters) - Vertex Pharmaceuticals ( VRTX ) raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments. The drugmaker now expects 2024 product revenue between $10.8 billion and $10.9 billion compared to its prior expectations of $10.65 billion to $10.85 billion. Analysts expect annual revenue of $10.75 billion,...
Diamondback Energy misses estimates for third-quarter profit
Diamondback Energy misses estimates for third-quarter profit
Nov 4, 2024
Nov 4 (Reuters) - Diamondback Energy ( FANG ) missed estimates for third-quarter profit on Monday as the oil and gas firm was hurt by lower prices. The company reported an adjusted profit of $3.38 per share for the quarter ended Sept. 30, compared with analysts' average estimate of $3.98 per share, according to data compiled by LSEG. (Reporting by...
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Nov 4, 2024
(Reuters) - Vertex Pharmaceuticals ( VRTX ) raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments. The drugmaker now expects 2024 product revenue between $10.8 billion and $10.9 billion compared to its prior expectations of $10.65 billion to $10.85 billion. Analysts expect annual revenue of $10.75 billion, according to...
--Vertex Pharmaceuticals Raises Full Year 2024 Product Revenue Guidance to $10.8-$10.9 Billion, vs Prior View of $10.65-$10.85 Billion
--Vertex Pharmaceuticals Raises Full Year 2024 Product Revenue Guidance to $10.8-$10.9 Billion, vs Prior View of $10.65-$10.85 Billion
Nov 4, 2024
04:03 PM EST, 11/04/2024 (MT Newswires) -- Price: 468.00, Change: -3.12, Percent Change: -0.66 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved